Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS)
$ 0.0371 0.0001 (0.27%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 1.45 GF Score: 16/100

Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript

Jul 25, 2022 / 12:30PM GMT
Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Good morning. This is Anna Marie Wagner. I'm the Senior Vice President of Corporate Development at Ginkgo Bioworks. I'm joined by Jason Kelly, our CEO and Co-Founder; and Mark Dmytruk, our CFO.

We're excited to host this special call with you today to update you on 2 exciting new acquisitions that were signed over the weekend. You can see more information in our press releases and Form 8-Ks that were released earlier this morning.

Also as a reminder, during the presentation today, we'll be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties.

And now without further ado, I'll hand it over to Jason.

Jason Kelly
Ginkgo Bioworks Holdings, Inc. - Co-Founder, CEO & Director

Thanks, Anna Marie. So our mission at Ginkgo is to make biology easier to engineer. And that's going to be especially important today. So we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot